2024.03.14
I-Mab Reports Full Year 2023 Financial Results and Business Update
The Company announced financial results for the full year ended December 31, 2023, and highlighted recent business updates.
2024.03.14
The Company announced financial results for the full year ended December 31, 2023, and highlighted recent business updates.
2024.02.07
The agreement marks an important milestone to advance the Company’s intent to become a U.S.-based biotech.
2023.11.06
The Company will have presentations and one-to-one meetings during the upcoming two investor conferences.
2023.10.17
2023.05.25
2023.04.11
2022.02.03
2021.07.09
2021.05.19